Chemcon Speciality Chemicals reported a strong second quarter for FY27, with revenue growing 22% and profit rising 31% to Rs 7.5 crore. Growth was powered by the organic chemicals segment, which offset weaker demand in inorganic chemicals. The company is actively deleveraging, with debt dropping significantly to Rs 27.3 crore, while it prepares to launch its new P11 manufacturing unit to drive future capacity.
Chemcon Speciality Chemicals Q2 Profit Grows 31% to Rs 7.5 Crore
Revenue for the quarter stood at Rs 65.4 crore, marking a 22% increase from the previous year.
Reader Takeaway: Strong organic chemical demand and debt reduction drive performance, while inorganic segment headwinds linger.
What just happened
Chemcon Speciality Chemicals released its financial results for Q2 FY27, showing a profit after tax (PAT) of Rs 7.5 crore, a 31% increase from Rs 5.7 crore in the same period last year. Revenue rose to Rs 65.4 crore from Rs 53.7 crore. The company reported significant margin improvement, with EBITDA hitting Rs 11 crore compared to Rs 6.9 crore a year prior.
Why this matters
The company’s organic chemicals segment—which includes products like HMDS and Bromobenzene—remains a core engine for growth, benefiting from consistent demand in the pharmaceutical and agrochemical sectors. Simultaneously, a sharp reduction in total borrowings from Rs 53.1 crore in March 2026 to Rs 27.3 crore in September 2026 reflects a disciplined approach to the balance sheet.
Risks to watch
Investors should note ongoing challenges in the inorganic chemicals segment (Bromides). This division is currently facing pressure from global geopolitical uncertainties and reduced oil drilling activity, which has dampened volume growth. Continued crude oil price volatility remains a structural risk factor for this specific business segment.
What to track next
The primary growth catalyst to monitor is the upcoming P11 manufacturing unit. Its successful commissioning is expected to bolster organic chemical output. Shareholders will be watching for updates on the timeline for this facility to reach full commercial production capacity.